🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 13463J101
- IPO
- 10/13/2024 · $11.00/share
Business: CAMP4 Therapeutics Corp is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression. CAMP4’s RAP platform™ enables the mapping of regulatory RNA (regRNA) sequences that function as master regulators of gene expression and the design of programmable therapeutic ASO candidates targeting these regRNAs.
Company Contact
- CEO
- Josh Mandel-Brehm
- CFO
- Kelly Gold
- Headquarters
- 100 Talcott Avenue, Suite 201, Watertown, MA 02472
- Phone
- 617-651-8867
- Investor Relations
- Ashley Robinson, LifeSci Advisors · arr@lifesciadvisors.com